You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 21 No. 1, July 1969 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Sulfatides and Demyelination

Subcellular Localization in Metachromatic Leukodystrophy

Michael J. Malone, MD; Jane Conole, BS

Arch Neurol. 1969;21(1):32-43.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

METACHROMATIC leukodystrophy (MLD) is a progressive, demyelinating disorder which is characterized chemically by the accumulation of a class of acidic glycolipids: the sulfatides. Pathologically, demyelination involves both the central nervous system (CNS) and peripheral nervous system, and granular, metachromatic deposits are spread throughout the neuraxis. Similar metachromatic granular material is found both intracellularly and as deposits in the tubules of the kidneys, adrenal glands, gallbladder, and liver.1

Austin et al2 first suggested the presence of an enzyme defect in MLD, and Mehl and Jatzkewitz,3 after demonstrating desulfation of sulfatides to cerebrosides in vitro, have shown a deficiency in a degradative enzyme system, cerebroside sulfatase, in kidney tissue from a patient with MLD.4,5 Moser et al6 studied the turnover of injected sodium sulfate S-35 in patients with MLD. In comparison with control groups, a greatly prolonged isotope turnover was found in MLD. They concluded that . . . [Full Text PDF of this Article]


Author Affiliations

Boston

From the Department of Neurology, Boston University School of Medicine (Dr. Malone) and the Neurology Research Department, Boston Veterans Administration Hospital (Miss Conole) and the Research Laboratory, Joseph P. Kennedy Jr. Memorial Hospital, Boston.


Footnotes

Submitted for publication Sept 21, 1968; accepted Jan 7, 1969.

Reprint requests to Kennedy Memorial Hospital, 30 Warren St, Boston 02135 (Dr. Malone).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1969 American Medical Association. All Rights Reserved.